Michel Obeid

Lausanne Branch
Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

Journal: Nature reviews. Clinical oncology

Published: July 14, 2026

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Journal: Current cardiology reports

Published: May 17, 2026

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Journal: Journal for immunotherapy of cancer

Published: February 10, 2026

Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related Myocarditis.

Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related Myocarditis.

Journal: JACC. CardioOncology

Published: September 04, 2025

Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 24, 2025

Adverse effects of new therapeutic approaches in thoracic oncology

Adverse effects of new therapeutic approaches in thoracic oncology

Journal: Revue medicale suisse

Published: May 15, 2025

Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.

Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: April 11, 2025

Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma.

Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 07, 2025

Real World Multi-centre UK Review of Nivolumab Monotherapy in Metastatic Endometrial Cancer With Mismatch Repair Deficiency During COVID-19.

Real World Multi-centre UK Review of Nivolumab Monotherapy in Metastatic Endometrial Cancer With Mismatch Repair Deficiency During COVID-19.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: December 10, 2024

Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction.

Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction.

Journal: JACC. CardioOncology

Published: November 27, 2024

Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.

Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.

Journal: Journal for immunotherapy of cancer

Published: October 23, 2024

Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.

Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 09, 2024

Showing 1-12 of 50

Last Updated: 09/26/2026